期刊文献+

红细胞增多、双侧肾周积液伴单克隆免疫球蛋白血症 被引量:2

A case of erythrocytosis,perinephric fluid collections and monoclonal gammopathy
下载PDF
导出
摘要 老年男性,病程3年余,体检发现双侧胸腔积液,伴前胸部皮肤毛细血管扩张,1年后发现双侧胸腔、腹腔和盆腔积液,红细胞增多,血红细胞生成素(EPO)水平升高,血免疫固定电泳阳性,骨髓细胞学未见明显异常,外院诊断“真性红细胞增多症”,给予羟基脲治疗,血红蛋白控制在正常范围。1月前发现双侧肾周大量积液,腹壁皮肤脂肪活检示刚果红染色阳性,考虑为系统性淀粉样变性。至国家肾脏疾病临床医学研究中心重复腹壁皮肤脂肪活检示刚果红染色阴性,免疫固定电泳图谱见κ型IgG单克隆免疫球蛋白条带,骨髓流式示0.3%异常克隆浆细胞,右心声学造影提示小肺动静脉分流,明确诊断为TEMPI综合征。接受8个疗程硼替佐米+地塞米松化疗后,血清免疫固定电泳转阴,EPO降至正常范围,皮肤毛细血管扩张基本消失,肾周积液明显减少。 A 71-year-old man presented with bilateral pleural effusion and telangiectasia for more than 3 years.One year later,bilateral pleural,abdominal and pelvic effusion were showed on PET-CT.Erythrocytosis with high erythropoietin(EPO),and monoclonal gammopathy were found,while bone marrow cytology showed no obvious abnormity.He was diagnosed with polycythemia vera and received long-term treatment with hydroxyurea.Bilateral perirenal effusion was found 3 years after the onset of the disease.The subcutaneous fat biopsy showed Congo red staining positive,and systemic amyloidosis was considered at another hospital.After admission to our hospital,serum immunofixation showed IgGκmonoclonal protein,bone marrow flow cytometry showed 0.3%abnormal clonal plasma cells,and right heart contrast echocardiography suggested arteriovenous shunting.The diagnosis of TEMPI syndrome was confirmed,and he subsequently received a total of eight cycles of bortezomib and dexamethasone,after which his serum immunofixation electrophoresis turned negative,EPO level decreased to normal,skin telangiectasis and perirenal fluid improved significantly.
作者 郭锦洲 赵亮 黄湘华 GUO Jinzhou;ZHAO Liang;HUANG Xianghua(National Clinical Research Center of Kidney Diseases,Jinling Hospital,Nanjing University School of Medicine,Nanjing 210016,China)
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2022年第1期95-100,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 TEMPI综合征 红细胞增多 单克隆免疫球蛋白血症 毛细血管扩张 肾周积液 TEMPI syndrome erythrocytosis monoclonal gammopathy telangiectasia perinephric fluid
  • 相关文献

参考文献1

二级参考文献15

  • 1朱卫国,王玉,曾学军,王强,沈悌.POEMS综合征32例临床分析[J].中华内科杂志,2006,45(2):108-111. 被引量:46
  • 2Scarlato M, Previtali SC. POEMS syndrome: the matter-of-fact approach. Curr Opin Neurol. , 2011,24 ( 5 ) :491 - 496.
  • 3Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome : definition and long-term outcome. Blood,2003, 101 (7) :2496 -2506.
  • 4Nakamoto Y, Imai H, Yasuda T, et al. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrnl Dial Transplant, 1999,14 (10) :2370 - 2378.
  • 5Modesto-Segonds A, Rey JP, Orfila C, et al. Renal involvement in POEMS syndrome. Clin Nephrol,1995,43 (5) :342 -345.
  • 6Soubrier M, Sauron C, Souweine B, et al. Growth fact ors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kindey Dis, 1999,34 (4) :633 - 638.
  • 7Li J,Zhou DB, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol, 2011,90(7) :819 -826.
  • 8Fukatsu A,Tamai H,Nishikawa K, et al. The kidney disease of Crow- Fukase (POEMS) syndrome: a clinico-pathological study of four cases. Clin Nephrol, 1991,36(2) :76 - 82.
  • 9Watanabe O, Afimura K, Kitajima I, et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet, 1996,347 ( 9002 ) : 702.
  • 10Storkebaum E, Lambrechts D, Dewerchin M, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci ,2005,8( 1 ) :85 -92.

共引文献8

同被引文献2

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部